Thomas Scanlon
5Patents
1h-index
7Co-inventors
40Inventor score
Filing activity: Jan 19, 2010 → May 22, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9074201B2 | Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US9699917B2 | Formulated resin compositions for flood coating electronic circuit assemblies | Electricity | 0 | Active |
| US9950041B2 | Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US9832902B2 | Formulated resin compositions for flood coating electronic circuit assemblies | Electricity | 0 | Active |
| US12312607B2 | AAV9 affinity agents | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.